Last reviewed · How we verify

NCT05947526

Outcomes of the Embryos of Different Ovarian Follicle Sizes, and the miRNA Detection in Their Blastocyst Culture

Status unknown Last updated 17 July 2023
What this trial tests

trial testing Oocyte pick-up in Embryo Quality in 55 participants. Status unknown.

Timeline
20 June 2023
Primary endpoint
20 October 2023
10 December 2023

Quick facts

Lead sponsorAcibadem University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment55
Start date20 June 2023
Primary completion20 October 2023
Estimated completion10 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Acibadem University

Who can join

Adults 20 to 38, female only, with Embryo Quality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, it is aimed to analyze the outcomes of embryos obtained from ovarian follicle with different sizes, and identify the microRNA expression in the spent media of the blastocysts cultures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Acibadem University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05947526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing